| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 18,971 | 18,007 | 17,197 | | Cost of Revenue | 1,910 | 1,854 | 1,744 | | | Gross Profit | 17,061 | 16,154 | 15,453 | | | Operating Expenses | | Research Development | 3,579 | 2,904 | 3,004 | | Selling General and Administrative | 11,403 | 10,660 | 10,101 | | Non Recurring |
-
|
-
|
-
| | Others | 82 | 82 | 82 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,997 | 2,507 | 2,265 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (99) | (91) | (42) | | Earnings Before Interest And Taxes | 1,898 | 2,416 | 2,223 | | Interest Expense | 0 | 1 | 0 | | Income Before Tax | 1,898 | 2,415 | 2,222 | | Income Tax Expense | 48 | 75 | 89 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,850 | 2,340 | 2,133 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,850 | 2,340 | 2,133 | | Preferred Stock And Other Adjustments | (49) | (631) | (631) | | | Net Income Applicable To Common Shares | $1,801 | $1,709 | $1,502 |
|
0.41% Nasdaq 
0.12 (0.61%) 
Income Statement
